CD274 and non-small cell lung carcinoma: Gong and colleagues [38] have detected five PD-L1 splice variants from NSCLC patients who relapsed from anti-PD-L1 therapy, consisting of a full-length variant encoding a membrane-bound isoform and four variants encoding the soluble form of PD-L1, among which only two were proven to be stable.